Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model
ACS Chemical Neuroscience · 2023
DOI: 10.1021/acschemneuro.3c00348 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Wen-Han Chuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science and Technology, Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsinch…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Alzheimer Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: National Science and Technology Council, National Yang Ming Chiao Tung University-Kaohsiung Medical University joint project.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive impairment, memory loss, and behavioral deficits. β-amyloid1-42 (Aβ1-42) aggregation is a significant cause of the pathogenesis in AD. Despite the numerous types of research, the current treatment efficacy remains insufficient. Hence, a novel therapeutic strategy is required. Nitric oxide (NO) is a multifunctional gaseous molecule. NO displays a neuroprotective role in the central nervous system by inhibiting the Aβ aggregation and rescuing memory and learning deficit through the NO signaling pathway. Targeting the NO pathway might be a therapeutic option; however, NO has a limited half-life under the biological system. To address this issue, a biomimetic dinitrosyl iron complex [(NO)2Fe(μ-SCH2CH2COOH)2Fe(NO)2] (DNIC-COOH) that could stably deliver NO was explored in the current study. To determine whether DNIC-COOH exerts anti-AD efficacy, DNIC-COOH was added to neuron-like cells and primary cortical neurons along with Aβ1-42. This study found that DNIC-COOH protected neuronal cells from Aβ-induced cytotoxicity, potentiated neuronal functions, and facilitated Aβ1-42 degradation through the NO-sGC-cGMP-AKT-GSK3β-CREB/MMP-9 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science and Technology, Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
- Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 300, Taiwan.
- Department of Chemistry, National Tsing Hua University, Hsinchu 300, Taiwan.
- Department of Chemistry, Chung Yuan Christian University, Taoyuan 32023, Taiwan.
- Department of Biomedical Science and Environmental Biology, Department of Dentistry, Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
ORCID-Profile: Wen-Feng Liaw, Tsai-Te Lu, Yun-Ming Wang
Förderung
- National Science and Technology Council
- National Yang Ming Chiao Tung University-Kaohsiung Medical University joint project
Zitieren
APA
Chuang, W. H., Chou, Y. T., Chen, Y. H., Kuo, T. H., Liaw, W. F., Lu, T. T., Kao, C. F., & Wang, Y. M. (2023). Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00348
Vancouver
Chuang WH, Chou YT, Chen YH, Kuo TH, Liaw WF, Lu TT, et al. Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00348
BibTeX
@article{Chuang2023,
author = {Chuang, Wen-Han and Chou, Yu-Ting and Chen, Yi-Hong and Kuo, Ting-Han and Liaw, Wen-Feng and Lu, Tsai-Te and Kao, Chih-Fei and Wang, Yun-Ming},
title = {Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model},
journal = {ACS Chemical Neuroscience},
year = {2023},
doi = {10.1021/acschemneuro.3c00348}
}
EUVIMED